We're growing! Check out our job openings! Apply now!

My Quote
Cart
 

Demecolcine

Demecolcine

$50.00

Key features and details

Demecolcine, also known as colcemid, is a drug used in chemotherapy. It is closely related to the natural alkaloid colchicine with the replacement of the acetyl group on the amino moiety with methyl, but it is less toxic.

SKU: 02190195-CF

Synonyms
N-Deacetyl-N-methylcolchicine; 6,7-Dihydro-1,2,3,10-tetramethoxy-7-(methylamino)benzo[a]heptalen-9(5H)-one; N-Methyl-N-desacetylcolchicine; Colchamine; Santavy's substance F
CAS Number:
477-30-5
Molecular Formula:
C21H25NO5
Molecular Weight:
371.4
Beilstein Registry Number:
2822892
EC Number:
207-514-6
MDL Number:
MFCD00075459
Product Description

Demecolcine, also known as colcemid, is a drug used in chemotherapy. It is closely related to the natural alkaloid colchicine with the replacement of the acetyl group on the amino moiety with methyl, but it is less toxic.

Application Notes

Demecolcine is a antineoplastic agent used to immobilize chromosomes by inactivating the spindle fiber mechanism during metaphase. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.

Usage Statement

Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.

Key Applications

Antineoplastic agent | Cancer research

Specifications
SKU 02190195-CF
Apply Add To Quote No
Alternate Names N-Deacetyl-N-methylcolchicine; 6,7-Dihydro-1,2,3,10-tetramethoxy-7-(methylamino)benzo[a]heptalen-9(5H)-one; N-Methyl-N-desacetylcolchicine; Colchamine; Santavy's substance F
Application Notes Demecolcine is a antineoplastic agent used to immobilize chromosomes by inactivating the spindle fiber mechanism during metaphase. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.
Base Catalog Number 190195
Beilstein Registry Number 2822892
Biochemical Physiological Actions Demecolcine depolymerizes microtubules; blocks mitosis at metaphase. Often in karyotyping and cell cycle research it is desirable to increase the yield of mitotic cells in a particular phase of the cell cycle. This can be achieved in a variety of ways with the most popular being the use of a cell cycle synchronizing agent such as demecolcine. Demecolcine will arrest cells in metaphase with no remarkable effect on the biochemical events in mitotic cells or in synchronized G1 and S phase cells. White blood cells are often treated with demecolcine to arrest cells in metaphase.
CAS # 477-30-5
EC Number 207-514-6
Hazard Statements H300
Melting Point 186 °C (Lit.)
Molecular Formula C21H25NO5
Molecular Weight 371.4
Personal Protective Equipment Eyeshields, Faceshields, Gloves, respirator cartridges
Purity >98%
RTECS Number GH0800000
Safety Symbol GHS06
Solubility Soluble in acidified water, alcohol, ether, chloroform (10 mg/mL - clear, faint yellow solution) and benzene.
Typical Working Concentration Used in cell culture medium at a final concentration of 0.4 ug/mL.
Usage Statement Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Documents

Certificate of Analysis (COA)